PRTA PROTHENA CORP PLC

Ownership history in Birchview Capital, LP  ·  20 quarters on record

This page tracks every 13F SEC filing in which Birchview Capital, LP reported a position in PROTHENA CORP PLC (PRTA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
7.99% (2023 Q2)
Avg. % of fund
3.46%
First filed
2017 Q3
Last filed
2025 Q4
Quarters held
20
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 441,019 -108,000 -19.7% 2.47% $4.2M $9.55
2025 Q3 ADDED 549,019 +98,000 +21.7% 4.05% $5.4M $9.76
2025 Q2 ADDED 451,019 +118,045 +35.5% 2.72% $2.7M $6.07
2025 Q1 ADDED 332,974 +28,400 +9.3% 3.58% $4.1M $12.38
2024 Q4 ADDED 304,574 +95,000 +45.3% 3.44% $4.2M $13.85
2024 Q3 ADDED 209,574 +6,000 +2.9% 3.04% $3.5M $16.73
2024 Q2 ADDED 203,574 +34,000 +20.1% 3.89% $4.2M $20.64
2024 Q1 UNCHANGED 169,574 0% 3.43% $4.2M $24.77
2023 Q4 UNCHANGED 169,574 0% 4.83% $6.2M $36.34
2023 Q3 ADDED 169,574 +13,463 +8.6% 6.96% $8.2M $48.25
10 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    PRTA price (monthly, adj. close)
← Back to Birchview Capital, LP Holdings